Spikevax XBB.1.5 0.1 mg/mL dispersion for injection
Spikevax XBB.1.5 50 micrograms dispersion for injection
Spikevax XBB.1.5 50 micrograms dispersion for injection in pre-filled syringe
Spikevax XBB.1.5 is indicated for active immunisation to prevent COVID‑19 caused by SARS-CoV-2 in individuals 12 years of age and older.
Spikevax bivalent Original/Omicron BA.1 (50 micrograms/50 micrograms)/mL dispersion for injection
Spikevax bivalent Original/Omicron BA.1 is indicated as a 50 microgram booster dose in adults who previously received the primary vaccination or a primary vaccination with first booster dose of an original monovalent vaccine.
Spikevax (previously COVID-19 Vaccine Moderna)
Emergency Use Authorization (EUA) has been granted in Saudi Arabia for Spikevax to prevent COVID-19 (coronavirus disease 2019) in people from 6 years of age.
Tools
Contact Moderna
8am-5pm AST – Sun - Thr
EMEAMedinfo@modernatx.com